“UC San Diego is a community of changemakers and innovators,” said UC San Diego Chancellor Pradeep K. Khosla Sept. 28 as he welcomed a crowd in Atkinson Hall at the IBM-UC San Diego signing ceremony celebration. “It is not an exaggeration to say that at this campus, which in its short time of 57 years is the top ten in the country and top 15 in the world, we must have done something right.
Patients at UC San Diego Health in need of radiation therapy now have access to the next generation of radiation treatment technology. The new radiotherapy system significantly reduces treatment times with improved accuracy.
In a first-of-its-kind study, University of California San Diego School of Medicine researchers report that a blood sample, or liquid biopsy, can reveal which patients will respond to checkpoint inhibitor-based immunotherapies.
Researchers at University of California San Diego School of Medicine have developed the first mice that lack the Upf3b gene, providing a new model for studying its underlying role in intellectual disabilities and neurodevelopmental disorders.
Using a form of low-impulse electrical stimulation to the brain, documented by neuroimaging, researchers at the University of California San Diego School of Medicine, Veterans Affairs San Diego Healthcare System (VASDHS) and collaborators elsewhere, report significantly improved neural function in participants with mild traumatic brain injury (TBI).
A team of researchers has engineered smart protein molecules that can reprogram white blood cells to ignore a self-defense signaling mechanism that cancer cells use to survive and spread in the body. Researchers say the advance could lead to a new method of re-engineering immune cells to fight cancer and infectious diseases. The team successfully tested this method in a live cell culture system.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
